BCL6B and cancer: As shown in Table 1, BCL6B protein expression in cancer tissues from the quantitative PCR cohort was significantly correlated with clinicopathological features such as hepatitis B infection, liver cirrhosis and portal vein tumor thrombus (PVTT) (p < 0.05 for all).